Back

Impact of body mass index on the long-term outcome of pulsed-field ablation for atrial fibrillation

12 April 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Poster session (1): supraventricular arrhythmias Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Sanghamitra Mohanty

St. David's Medical Center, Austin (United States of America)

196 More presentations in this session

Presentation thumbnail
Electrocardiographic differentiation of narrow QRS complex tachycardia: validation of the new aVL and aVR criteria and a unifying approach to ECG analysis
Doctor J. Stec (Cracow, PL)
Abstract Slides Video
Presentation thumbnail
Characterization of paroxysmal atrial fibrillation in atrial septal defects: contribution of a left atrial substrate
Doctor N. Ramdat Misier (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Spatial distribution of effective refractory period in atrial fibrillation patients
Associate Professor A. Loewe (Karlsruhe, DE)
Abstract Slides
Presentation thumbnail
Early onset atrial fibrillation as a marker of inherited cardiomyopathy: lessons from combined imaging and genetic assessment
Doctor V. Rella (Milan, IT)
Abstract Slides Video
Presentation thumbnail
BMI discrepancy and new-onset atrial fibrillation: findings from UK biobank
Doctor J. Choi (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session (1): supraventricular arrhythmias

The Event

Event poster

EHRA 2026

12 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of effectiveness and outcomes of pulsed field ablation of atrial fibrillation in patients with obesity
thumbnail
Congress Presentation
1 year clinical & safety outcome of obese patients undergoing PVI for atrial fibrillation with pulsed field or cryoballoon ablation - a prospensity matched analysis
thumbnail
Congress Presentation
Impact of obesity and early recurrence of atrial fibrillation on very late recurrence following cryoballoon pulmonary vein isolation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources